Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 6888 | 10.565 |
09:34 ET | 2427 | 10.53 |
09:36 ET | 900 | 10.77 |
09:38 ET | 16811 | 10.69 |
09:39 ET | 1015 | 10.695 |
09:41 ET | 2200 | 10.69 |
09:43 ET | 3200 | 10.685 |
09:45 ET | 1416 | 10.645 |
09:48 ET | 3644 | 10.68 |
09:50 ET | 1230 | 10.55 |
09:52 ET | 846 | 10.7 |
09:54 ET | 450 | 10.655 |
09:57 ET | 285 | 10.63 |
09:59 ET | 619 | 10.59 |
10:01 ET | 916 | 10.575 |
10:03 ET | 2099 | 10.58 |
10:08 ET | 894 | 10.6262 |
10:10 ET | 1200 | 10.618 |
10:12 ET | 1143 | 10.63 |
10:14 ET | 600 | 10.6299 |
10:15 ET | 1755 | 10.7 |
10:17 ET | 11510 | 10.66 |
10:19 ET | 374 | 10.63 |
10:21 ET | 400 | 10.675 |
10:24 ET | 600 | 10.71 |
10:26 ET | 1700 | 10.67 |
10:28 ET | 200 | 10.66 |
10:30 ET | 224 | 10.665 |
10:32 ET | 800 | 10.64 |
10:35 ET | 204 | 10.635 |
10:37 ET | 740 | 10.61 |
10:42 ET | 501 | 10.57 |
10:44 ET | 695 | 10.6 |
10:46 ET | 684 | 10.5619 |
10:48 ET | 13809 | 10.52 |
10:50 ET | 300 | 10.59 |
10:51 ET | 505 | 10.555 |
10:53 ET | 3733 | 10.625 |
10:55 ET | 608 | 10.625 |
10:57 ET | 677 | 10.625 |
11:00 ET | 747 | 10.62 |
11:02 ET | 700 | 10.595 |
11:04 ET | 550 | 10.55 |
11:06 ET | 300 | 10.555 |
11:08 ET | 300 | 10.555 |
11:09 ET | 900 | 10.6 |
11:15 ET | 7683 | 10.59 |
11:18 ET | 453 | 10.59 |
11:20 ET | 702 | 10.58 |
11:22 ET | 200 | 10.57 |
11:24 ET | 95415 | 10.59 |
11:26 ET | 400 | 10.595 |
11:27 ET | 200 | 10.595 |
11:29 ET | 100 | 10.595 |
11:31 ET | 1482 | 10.595 |
11:33 ET | 675 | 10.59 |
11:36 ET | 100 | 10.575 |
11:38 ET | 896 | 10.55 |
11:40 ET | 100 | 10.56 |
11:42 ET | 100 | 10.57 |
11:47 ET | 1845 | 10.64 |
11:49 ET | 728 | 10.6407 |
11:51 ET | 522 | 10.63 |
11:54 ET | 670 | 10.64 |
11:56 ET | 7685 | 10.6301 |
11:58 ET | 16143 | 10.6349 |
12:00 ET | 940 | 10.62 |
12:02 ET | 300 | 10.625 |
12:03 ET | 700 | 10.59 |
12:05 ET | 600 | 10.57 |
12:07 ET | 1600 | 10.56 |
12:09 ET | 1000 | 10.565 |
12:12 ET | 3391 | 10.58 |
12:14 ET | 4702 | 10.57 |
12:16 ET | 1708 | 10.585 |
12:18 ET | 200 | 10.59 |
12:20 ET | 300 | 10.6 |
12:21 ET | 700 | 10.575 |
12:23 ET | 2427 | 10.58 |
12:25 ET | 242 | 10.57 |
12:27 ET | 300 | 10.575 |
12:30 ET | 200 | 10.565 |
12:32 ET | 2037 | 10.6 |
12:34 ET | 3287 | 10.58 |
12:36 ET | 1800 | 10.605 |
12:38 ET | 1036 | 10.59 |
12:39 ET | 553 | 10.58 |
12:41 ET | 200 | 10.58 |
12:43 ET | 1293 | 10.61 |
12:48 ET | 277 | 10.59 |
12:50 ET | 400 | 10.59 |
12:52 ET | 100 | 10.59 |
12:56 ET | 2528 | 10.6 |
12:57 ET | 300 | 10.59 |
12:59 ET | 1160 | 10.61 |
01:01 ET | 300 | 10.605 |
01:03 ET | 100 | 10.62 |
01:06 ET | 806 | 10.615 |
01:08 ET | 2043 | 10.61 |
01:10 ET | 1423 | 10.615 |
01:12 ET | 877 | 10.61 |
01:14 ET | 700 | 10.6 |
01:15 ET | 100 | 10.595 |
01:17 ET | 3493 | 10.57 |
01:19 ET | 1130 | 10.59 |
01:24 ET | 783 | 10.6 |
01:26 ET | 200 | 10.585 |
01:28 ET | 1578 | 10.605 |
01:30 ET | 2044 | 10.615 |
01:32 ET | 954 | 10.62 |
01:33 ET | 100 | 10.61 |
01:35 ET | 2070 | 10.63 |
01:37 ET | 900 | 10.59 |
01:39 ET | 8050 | 10.5722 |
01:42 ET | 822 | 10.5744 |
01:44 ET | 1365 | 10.57 |
01:46 ET | 2002 | 10.59 |
01:48 ET | 1041 | 10.585 |
01:50 ET | 200 | 10.585 |
01:51 ET | 1453 | 10.56 |
01:53 ET | 1213 | 10.55 |
01:55 ET | 650 | 10.52 |
01:57 ET | 10328 | 10.45 |
02:00 ET | 1755 | 10.42 |
02:02 ET | 1947 | 10.41 |
02:04 ET | 100 | 10.39 |
02:06 ET | 3892 | 10.42 |
02:08 ET | 1941 | 10.42 |
02:09 ET | 1671 | 10.445 |
02:11 ET | 200 | 10.445 |
02:13 ET | 2600 | 10.465 |
02:15 ET | 3400 | 10.505 |
02:18 ET | 2200 | 10.505 |
02:20 ET | 200 | 10.49 |
02:22 ET | 600 | 10.49 |
02:24 ET | 600 | 10.49 |
02:26 ET | 1564 | 10.48 |
02:27 ET | 705 | 10.48 |
02:29 ET | 1986 | 10.49 |
02:31 ET | 4946 | 10.46 |
02:33 ET | 100 | 10.4598 |
02:36 ET | 400 | 10.46 |
02:38 ET | 300 | 10.46 |
02:40 ET | 3500 | 10.44 |
02:42 ET | 2161 | 10.45 |
02:44 ET | 4400 | 10.47 |
02:45 ET | 1213 | 10.49 |
02:47 ET | 200 | 10.48 |
02:49 ET | 700 | 10.48 |
02:51 ET | 1200 | 10.48 |
02:54 ET | 500 | 10.44 |
02:56 ET | 2438 | 10.44 |
02:58 ET | 1235 | 10.46 |
03:00 ET | 800 | 10.45 |
03:02 ET | 912 | 10.44 |
03:03 ET | 3415 | 10.45 |
03:05 ET | 2000 | 10.46 |
03:07 ET | 3256 | 10.52 |
03:09 ET | 1000 | 10.47 |
03:12 ET | 203 | 10.48 |
03:14 ET | 27198 | 10.5 |
03:16 ET | 2996 | 10.5 |
03:18 ET | 2700 | 10.525 |
03:20 ET | 5136 | 10.625 |
03:21 ET | 3648 | 10.62 |
03:23 ET | 1149 | 10.655 |
03:25 ET | 9593 | 10.65 |
03:27 ET | 413 | 10.63 |
03:30 ET | 1579 | 10.59 |
03:32 ET | 1200 | 10.585 |
03:34 ET | 3834 | 10.619 |
03:36 ET | 1755 | 10.615 |
03:38 ET | 957 | 10.64 |
03:39 ET | 1069 | 10.6 |
03:41 ET | 7511 | 10.62 |
03:43 ET | 2445 | 10.605 |
03:45 ET | 2311 | 10.61 |
03:48 ET | 1441 | 10.59 |
03:50 ET | 3107 | 10.56 |
03:52 ET | 4370 | 10.49 |
03:54 ET | 7163 | 10.58 |
03:56 ET | 6745 | 10.59 |
03:57 ET | 13220 | 10.59 |
03:59 ET | 40591 | 10.52 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 376.0M | -3.0x | --- |
Aura Biosciences Inc | 364.1M | -3.9x | --- |
LENZ Therapeutics Inc | 396.0M | -1.0x | --- |
ACELYRIN Inc | 401.1M | -1.6x | --- |
Anavex Life Sciences Corp | 350.4M | -8.2x | --- |
Fibrobiologics Inc | 403.1M | -11.8x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $376.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.